Regal Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 24-06-2024
- Paid Up Capital ₹ 1.05 Cr
as on 24-06-2024
- Company Age 29 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.26 Cr
as on 24-06-2024
- Revenue 23.12%
(FY 2022)
- Profit 137.14%
(FY 2022)
- Ebitda 45.27%
(FY 2022)
- Net Worth 27.20%
(FY 2022)
- Total Assets -2.24%
(FY 2022)
About Regal Remedies
The Corporate was formerly known as Regal Remedies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.05 Cr.
The company currently has active open charges totaling ₹6.26 Cr.
Hemantkumar Patel, Ankit Kakadiya, Alpeshkumar Savaliya, and One other member serve as directors at the Company.
- CIN/LLPIN
U36912MH1995PLC088280
- Company No.
088280
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 May 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Regal Remedies Limited offer?
Regal Remedies Limited offers a wide range of products and services, including Potassium Salts, Potassium Fluoride, Chemical Reagents & Catalysts, Ammonium Compound.
Who are the key members and board of directors at Regal Remedies?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemantkumar Patel  | Director | 15-Jul-2015 | Current |
| Ankit Kakadiya | Director | 28-Aug-2018 | Current |
| Alpeshkumar Savaliya | Director | 15-Jul-2015 | Current |
| Bhavesh Savani | Director | 24-Jul-2006 | Current |
Financial Performance of Regal Remedies.
Regal Remedies Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.12% increase. The company also saw a substantial improvement in profitability, with a 137.14% increase in profit. The company's net worth Soared by an impressive increase of 27.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Regal Remedies?
In 2022, Regal Remedies had a promoter holding of 0.29% and a public holding of 99.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 31 Aug 2020 | ₹8.20 M | Open |
Axis Bank Limited Creation Date: 21 Nov 2017 | ₹5.44 Cr | Open |
How Many Employees Work at Regal Remedies?
Regal Remedies has a workforce of 50 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Regal Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regal Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
